🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MindBio Therapeutics Corp. (CSE:MBIO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0900
-0.0050 (-5.26%)
Nov 20, 2026, 1:49 PM EST

MindBio Therapeutics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Selling, General & Admin
1.861.060.631.822.9
Research & Development
----2.46
Amortization of Goodwill & Intangibles
----0.04
Operating Expenses
3.691.90.633.225.4
Operating Income
-3.69-1.9-0.63-3.22-5.4
Interest Expense
-0.28-0.58-0.35-0.45-0.18
Currency Exchange Gain (Loss)
0.19--0.01-0.11
Other Non Operating Income (Expenses)
-0.22-0.030.58-0.25-1.78
EBT Excluding Unusual Items
-3.99-2.51-0.41-3.92-7.47
Gain (Loss) on Sale of Investments
---0.01-0.02-
Asset Writedown
-0.63-0.59---
Other Unusual Items
0.070.290.01-0.35-
Pretax Income
-4.55-2.81-0.41-4.29-7.47
Earnings From Continuing Operations
-4.55-2.81-0.41-4.29-7.47
Minority Interest in Earnings
0.010.01---
Net Income
-4.54-2.8-0.41-4.29-7.47
Net Income to Common
-4.54-2.8-0.41-4.29-7.47
Net Income Growth
-----
Shares Outstanding (Basic)
41000
Shares Outstanding (Diluted)
41000
Shares Change
691.66%54.23%20.80%106.14%-
EPS (Basic)
-1.12-5.46-1.24-15.57-55.96
EPS (Diluted)
-1.12-5.46-1.24-15.57-55.96
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EBITDA
--1.78---5.36
D&A For EBITDA
-0.12--0.04
EBIT
-3.69-1.9-0.63-3.22-5.4